10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 473,966 | 344,067 | 359,284 | 222,379 | 588,475 |
| Marketable Securities | 49,443 | 49,335 | 29,411 | 210,238 | N/A |
| Receivables | 82,493 | 88,468 | 114,832 | 104,211 | 85,254 |
| Inventories | 56,341 | 83,107 | 73,706 | 81,629 | 59,966 |
| TOTAL | $684,451 | $584,387 | $596,022 | $635,035 | $747,591 |
| Non-Current Assets | |||||
| PPE Net | 226,711 | 252,648 | 279,571 | 289,328 | 169,492 |
| Intangibles | 66,840 | 20,182 | 21,127 | 27,369 | 29,908 |
| Other Non-Current Assets | 63,363 | 61,419 | 68,423 | 77,248 | 71,835 |
| TOTAL | $356,914 | $334,249 | $369,121 | $393,945 | $271,235 |
| Total Assets | $1,041,365 | $918,636 | $965,143 | $1,028,980 | $1,018,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,733 | 12,909 | 15,738 | 21,599 | 17,351 |
| Accrued Expenses | 82,471 | 74,780 | 86,753 | 92,454 | 82,535 |
| Other current liabilities | 23,363 | N/A | N/A | N/A | N/A |
| TOTAL | $153,454 | $117,633 | $127,162 | $130,957 | $110,357 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,902 | 20,658 | 13,150 | 7,867 | 5,340 |
| Other Non-Current Liabilities | 81,084 | 78,356 | 88,124 | 89,115 | 90,901 |
| TOTAL | $91,585 | $90,869 | $96,938 | $92,280 | $90,901 |
| Total Liabilities | $245,039 | $208,502 | $224,100 | $223,237 | $201,258 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,752 | 122,302 | 119,167 | 115,357 | 112,845 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,510,591 | -1,467,047 | -1,284,420 | -1,029,321 | -863,321 |
| Other shareholders' equity | 225 | -493 | -429 | -4,335 | 22 |
| TOTAL | $796,326 | $710,134 | $741,043 | $805,743 | $817,568 |
| Total Liabilities And Equity | $1,041,365 | $918,636 | $965,143 | $1,028,980 | $1,018,826 |